The molecular biology of gastrointestinal cancer: implications for diagnosis and therapy
- PMID: 18674693
- PMCID: PMC2561895
- DOI: 10.1016/j.giec.2008.03.003
The molecular biology of gastrointestinal cancer: implications for diagnosis and therapy
Abstract
Cancers are caused by the sequential accumulation of alterations in genes that control the growth, differentiation, and other behaviors of cells. It has long been recognized that cancers are very heterogeneous pathologically, which is a reflection of the variable genetic lesions that give rise to the variety of lesions present in the gastrointestinal tract. Despite this complexity, certain types of genetic alterations are linked to specific pathologic lesions. This review summarizes the current understanding of the molecular pathogenesis of gastrointestinal neoplasia and provides explanations for some of the pathologic variability of lesions encountered by the endoscopist.
Similar articles
-
Gastrointestinal carcinoid tumors: diagnosis and treatment.Chirurgia (Bucur). 2010 Nov-Dec;105(6):759-66. Chirurgia (Bucur). 2010. PMID: 21351698 Review.
-
Biomarkers in gastrointestinal cancers.Am J Gastroenterol. 2008 Aug;103(8):2106-10. doi: 10.1111/j.1572-0241.2008.01994.x. Epub 2008 Jul 12. Am J Gastroenterol. 2008. PMID: 18637088 Free PMC article. Review. No abstract available.
-
[Molecular diagnosis on gastrointestinal cancers].Rinsho Byori. 1994 Apr;42(4):359-63. Rinsho Byori. 1994. PMID: 8176844 Review. Japanese.
-
Applications of EUS for the molecular characterization and treatment of gastrointestinal diseases--a review of the recent medical literature.MedGenMed. 2005 May 10;7(2):18. MedGenMed. 2005. PMID: 16369397 Free PMC article. Review. No abstract available.
-
Gastrointestinal cancers in the era of theranostics: Updates and future perspectives.World J Gastroenterol. 2015 Jul 28;21(28):8473-7. doi: 10.3748/wjg.v21.i28.8473. World J Gastroenterol. 2015. PMID: 26229391 Free PMC article. Review.
Cited by
-
Hepatoid Adenocarcinoma of the Stomach: A Challenging Diagnostic and Therapeutic Disease through a Case Report and Review of the Literature.Front Med (Lausanne). 2017 Sep 28;4:164. doi: 10.3389/fmed.2017.00164. eCollection 2017. Front Med (Lausanne). 2017. PMID: 29034239 Free PMC article.
-
Mutations in TGFbeta-RII and BAX mediate tumor progression in the later stages of colorectal cancer with microsatellite instability.BMC Cancer. 2010 Jun 18;10:303. doi: 10.1186/1471-2407-10-303. BMC Cancer. 2010. PMID: 20565851 Free PMC article.
-
Circulating tumour cell enumeration, biomarker analyses, and kinetics in patients with colorectal cancer and other GI malignancies.Front Oncol. 2023 Nov 17;13:1305181. doi: 10.3389/fonc.2023.1305181. eCollection 2023. Front Oncol. 2023. PMID: 38044994 Free PMC article.
-
The molecular characteristics of colorectal cancer: Implications for diagnosis and therapy.Oncol Lett. 2018 Jul;16(1):9-18. doi: 10.3892/ol.2018.8679. Epub 2018 May 9. Oncol Lett. 2018. PMID: 29928381 Free PMC article. Review.
-
Anticipation in lynch syndrome: where we are where we go.Curr Genomics. 2011 Nov;12(7):451-65. doi: 10.2174/138920211797904070. Curr Genomics. 2011. PMID: 22547953 Free PMC article.
References
-
- Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990;61(5):759–767. - PubMed
-
- Issa JP. CpG island methylator phenotype in cancer. Nat Rev Cancer. 2004;4(12):988–993. - PubMed
-
- Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996;87(2):159–170. - PubMed
-
- Vogelstein B, Fearon ER, Kern SE, et al. Allelotype of colorectal carcinomas. Science. 1989;244(4901):207–211. - PubMed
-
- Kern SE, Fearon ER, Tersmette KW, et al. Clinical and pathological associations with allelic loss in colorectal carcinoma [corrected] JAMA. 1989;261(21):3099–3103. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources